Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Burden of Cardiovascular Disease in Hsct Publisher



Emami AH1 ; Alizadehasl A2 ; Bezanjani FN2 ; Hajiali H2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Hematology-Oncology Department, Cancer Institute, Imam Khomeini Hospital, School of medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Cardio-Oncology Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran

Source: Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation Published:2024


Abstract

Cancers Cancer inflict the largest burden in the world. Burden of Cancer incidence and mortality is also growing. Hematopoietic stem cell transplantatio Hematopoietic Stem Cell Transplantation (HSCT) (HSCT) is a curative therapeutic method for malignant hematologic disorders and is associated with early and late treatment related mortality. Cardiac toxicity and cardiovascular consequences are not common in post HSCT patients compared to other HSCT Hematopoietic Stem Cell Transplantation (HSCT) related complications. However, these complications play an important role in survivors' outcome. It is necessary to identify and decrease these life-threatening complications to improve patients' outcome and decline related cost burden. © Springer Nature Switzerland AG 2024. All rights reserved.
Related Docs
View other Related Docs
1. Cardiovascular Diseases in Patients After Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-Analysis, Current Research in Translational Medicine (2023)
2. Pre-Hsct Cardiovascular Evaluation, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
3. Pericardial Disease in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
4. Hypertension in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
5. Risk Factors and Mechanisms of Cardiotoxicity in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
6. Long Term Cardiotoxicity Surveillance in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
7. A Novel Adc Targeting Cell Surface Fibromodulin in a Mouse Model of Triple-Negative Breast Cancer, Breast Cancer (2022)
8. Uncovering the Relationship Between Yap/ Wwtr1 (Taz) Genes Expression and Lncrnas of Snhg15, Hcp5 and Linc01433 in Breast Cancer Tissues, Pathology Research and Practice (2024)
Experts (# of related papers)
View all Related Experts
Kamran Roudini (3)
Amir Hossein Emami (2)
Other Related Docs
9. Microrna-184 in the Landscape of Human Malignancies: A Review to Roles and Clinical Significance, Cell Death Discovery (2023)
10. Shedding Light on the Side Effects of Immunotherapies Used for Leukemia: An Updated Review of the Literature, Expert Review of Anticancer Therapy (2023)
11. Low Expression of Isocitrate Dehydrogenase 1 (Idh1) R132h Is Associated With Advanced Pathological Features in Laryngeal Squamous Cell Carcinoma, Journal of Cancer Research and Clinical Oncology (2023)
12. Mortality Rates and Years of Life Lost Due to Cancer in Iran: Analysis of Data From the National Death Registration System, 2016, International Journal of Cancer Management (2022)
13. Cell-Based Vaccines: Frontiers in Medical Technology for Cancer Treatment, Regenerative Engineering and Translational Medicine (2024)
14. A Systematic Review and Comparative Evaluation to Develop and Validate a Comprehensive Framework for Cancer Surveillance Systems, Archives of Public Health (2025)
15. Fear of Cancer Recurrence and Coping Strategies Among Prostate Cancer Survivors: A Qualitative Study, Current Oncology (2023)